Language Selector

    IMI Launches Final Calls for Proposals

    Published on 25 June 2020
    Author: Nicole Wyss, National Contact Point Health

    The Innovative Medicines Initiative (IMI) is launching the last Calls for proposals under the IMI2 programme, with topics on tackling cancer through artificial intelligence, antimicrobial resistance, neurodegenerative diseases, rare disease diagnosis, and more. Deadline for submission is 29 Sep 2020.

    IMI will contribute a total of €59 million to the projects funded under the Calls; these funds come from Horizon 2020 and will support the participation in the projects of organisations such as universities, small and medium-sized enterprises, and patient groups. EFPIA companies and IMI Associated Partners will contribute €47 million, mostly as ‘in kind’ contributions (e.g. staff time, access to equipment, etc.).

    • IMI2 – Call 23 is a standard, two-stage Call for proposals with 6 topics
    • IMI2 – Call 22 is a single-stage Call to provide additional support to certain existing IMI2 projects to allow them to build on their achievements and maximise the impacts of their work

    A series of webinars, one for each topic, is being held by IMI. Presentations and recordings can be found here.

    More information